STOCK TITAN

Mobile-health Network and Online Pharmacy, Lifepack, Sign Partnership Facilitating Cooperation in Singapore and Indonesia

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Tags
partnership
Mobile-health Network Solutions (MNDR) partners with Lifepack to enhance healthcare accessibility in Indonesia through teleconsultations. Approximately 2,000 Indonesian physicians will be trained to provide remote patient care. The partnership allows patients to access teleconsultations and prescriptions through MaNaDr's platform, with prescriptions fulfilled by Lifepack. The program aims to start in May 2024 and roll out fully in Q4 2024, expecting to generate significant revenue over the years.
Mobile-health Network Solutions (MNDR) si allea con Lifepack per migliorare l'accessibilità alle cure sanitarie in Indonesia tramite teleconsultazioni. Circa 2.000 medici indonesiani verranno formati per fornire assistenza paziente a distanza. La partnership permetterà ai pazienti di accedere a teleconsultazioni e prescrizioni tramite la piattaforma di MaNaDr, con le prescrizioni fornite da Lifepack. Il programma prevede di iniziare a maggio 2024 e di essere completamente operativo nel quarto trimestre del 2024, con aspettative di generare notevoli entrate negli anni a venire.
Mobile-health Network Solutions (MNDR) se asocia con Lifepack para mejorar el acceso a la atención sanitaria en Indonesia a través de teleconsultas. Aproximadamente 2.000 médicos indonesios serán capacitados para proporcionar cuidados remotos a los pacientes. La asociación permitirá a los pacientes acceder a teleconsultas y recetas a través de la plataforma de MaNaDr, con recetas cumplidas por Lifepack. El programa tiene como objetivo comenzar en mayo de 2024 y estar completamente operativo en el cuarto trimestre de 2024, esperando generar ingresos significativos a lo largo de los años.
Mobile-health Network Solutions (MNDR)가 인도네시아에서 원격 의료 접근성을 개선하기 위해 Lifepack과 파트너십을 체결하고 텔레컨설테이션을 통해 보건 서비스를 향상시킵니다. 약 2,000명의 인도네시아 의사들이 원격 환자 치료를 제공하도록 훈련을 받게 됩니다. 이 파트너십을 통해 환자들은 MaNaDr의 플랫폼을 통해 텔레컨설테이션과 처방을 접근할 수 있으며, 처방은 Lifepack에 의해 이행됩니다. 이 프로그램은 2024년 5월에 시작하여 2024년 4분기에 완전히 출시될 예정이며, 향후 수년간 상당한 수익을 창출할 것으로 기대됩니다.
Mobile-health Network Solutions (MNDR) s'associe à Lifepack pour améliorer l'accessibilité aux soins de santé en Indonésie via des téléconsultations. Environ 2 000 médecins indonésiens seront formés pour fournir des soins à distance aux patients. Le partenariat permettra aux patients d'accéder à des téléconsultations et des prescriptions via la plateforme de MaNaDr, avec des prescriptions réalisées par Lifepack. Le programme est prévu pour débuter en mai 2024 et être pleinement opérationnel au quatrième trimestre de 2024, en espérant générer des revenus significatifs au fil des années.
Mobile-health Network Solutions (MNDR) geht eine Partnerschaft mit Lifepack ein, um die Zugänglichkeit zur Gesundheitsversorgung in Indonesien durch Telekonsultationen zu verbessern. Ungefähr 2.000 indonesische Ärzte werden geschult, um Fernbetreuung von Patienten zu leisten. Die Partnerschaft ermöglicht es Patienten, über die Plattform von MaNaDr Telekonsultationen und Verschreibungen zu erhalten, die von Lifepack erfüllt werden. Das Programm soll im Mai 2024 starten und im vierten Quartal 2024 vollständig ausgerollt werden, wobei erhebliche Einnahmen über die Jahre erwartet werden.
Positive
  • None.
Negative
  • None.

SINGAPORE, April 23, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) (“MaNaDr” or the “Company”), a pioneering Asia-Pacific (“APAC”) telehealth provider, has announced a strategic partnership with PT Indopasifik Teknologi Medika Indonesia, better known as Lifepack, an online prescription provider based in Indonesia. The collaboration aims to improve healthcare accessibility in Indonesia by bringing affordable and accessible healthcare to the population.

~2,000 Indonesian physicians to be on-boarded

Under the partnership, approximately 2,000 Indonesian physicians, including general practitioners and specialists, will be on-boarded and trained to provide effective patient teleconsultations through MaNaDr's platform. Once on the platform, these physicians will initiate an awareness program aimed at encouraging their Indonesian patients to consider the advantages of receiving medical care remotely via teleconsultations on MaNaDr's platform. These physicians will also gain access to the platform’s AI-enabled face-scan diagnostic tools for remote diagnosis and also have the opportunity to participate in medical symposiums and knowledge-sharing initiatives with their APAC colleagues.

AI-powered Teleconsultations by MaNaDr, with Prescriptions fulfilled by Lifepack

The partnership will permit Indonesian patients, via the use of a MaNaDr mobile app, to access teleconsultations from among these physicians– as well as other preferred general practitioners or specialists on the MaNaDr platform – from the comfort of their homes. The mobile app’s AI-enabled face-scan technology permits patients without measurement equipment to receive remote diagnosis. After a teleconsultation is complete, all medications prescribed by the physician will be automatically routed by the MaNaDr platform to Lifepack, which will fill the prescriptions and arrange delivery to the patient.


Lifepack Prescription Platform

"We are excited to partner with Lifepack to bring innovative healthcare solutions to Indonesia," said Co-CEO of MaNaDr, Dr. Siaw Tung Yeng, PBM, Senior Consultant Family Physician. "This partnership will not only benefit Indonesian physicians and patients but also contribute to the advancement of telemedicine in the region."

Natali Ardianto, CEO of Lifepack, expressed similar sentiments, stating, "The strategic partnership between MaNaDr and Lifepack aligns with our mission to deliver impactful innovations in healthcare. We look forward to providing Indonesian residents with affordable, quality and 24x7 near-instant access to prescriptions and consultations with this partnership."

Mr. Ardianto added that Lifepack will follow-up with chronic patients to ensure their medications have been delivered in a timely fashion. 

The program is set to commence in May 2024, with a full-scale rollout expected in Q4 of 2024.

MaNaDr and Lifepack said they believed the partnership represented, “a significant step towards delivering impactful healthcare innovations at reduced cost to Indonesia’s 270 million citizens.”

The parties also said they anticipate that as the program gains acceptance in Indonesia it would likely generate, “significant incremental revenue over the coming years.”

About Mobile-health Network Solutions

Ranked #41 in Financial Times 2024 listing of 500 High-growth Asia-Pacific Companies, we are the first telehealth provider from the Asia-Pacific region to be listed in the US. Through our MaNaDr platform, we offer personalized and reliable medical attention to users worldwide. Our platform allows our community of healthcare providers to have a broader reach to users through virtual clinics without any start-up costs and the ability to connect to a global network of peer-to-peer support groups and partners. Our range of seamless and hassle-free telehealth solutions includes teleconsultation services, prescription fulfillment and other personalized services such as weight management programs and gender-specific care. For more information, please visit https://investors.manadr.com/

About Lifepack

Apotek Lifepack is a modern and reliable pharmacy service that offers a variety of over-the-counter medications, prescription drugs, supplements, and medical equipment at affordable prices. We provide original, BPOM-licensed products and deliver nationwide across Indonesia. Lifepack services are available both online and offline, accessible through our website, social media channels, WhatsApp, and the mobile app.

FORWARD-LOOKING STATEMENTS

Certain statements contained in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements relating to the expected trading commencement and closing dates. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company’s expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company’s ability to execute our strategies, manage growth and maintain our corporate culture; the Company’s future business development, financial conditions and results of operations; expectations regarding demand for and market acceptance of our products and services; changes in technology; economic conditions; the growth of the telehealth solutions industry in Singapore and the other international markets the Company plans to serve; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in Singapore and the international markets the Company plans to serve and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Any forward-looking statements contained in this press release speak only as of the date hereof, and Mobile-health Network Solutions specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law.

For media inquiries, please contact:

Mobile-health Network Solutions Investor Relations Contact:

2 Venture Drive, #07-06/07 Vision Exchange

Singapore 608526

(+65) 6222 5223

Email: investors@manadr.com

Lifepack Media Contact:

Graha Irama, 10th Floor Room C-D

Jl. HR. Rasuna Said Block X-1 Kav. 1-2,

Kuningan, Daerah Khusus Ibukota Jakarta 12950

E-mail: marketing@itmi.id

Investor Relations Inquiries:

Skyline Corporate Communications Group, LLC

Scott Powell, President

1177 Avenue of the Americas, 5th Floor

New York, New York 10036

Office: (646) 893-5835

Email: info@skylineccg.com

Attachment


FAQ

What is the partnership between Mobile-health Network Solutions and Lifepack about?

The partnership aims to enhance healthcare accessibility in Indonesia through teleconsultations, training 2,000 Indonesian physicians to provide remote patient care.

How will patients access teleconsultations and prescriptions through MaNaDr's platform?

Patients can access teleconsultations and prescriptions through MaNaDr's platform using a mobile app, with prescriptions being fulfilled by Lifepack.

When will the program start, and when is the full-scale rollout expected?

The program is set to commence in May 2024, with a full-scale rollout expected in Q4 of 2024.

What is the expected outcome of the partnership in terms of revenue?

The parties anticipate that the program will likely generate significant incremental revenue over the coming years as it gains acceptance in Indonesia.

Mobile-health Network Solutions

NASDAQ:MNDR

MNDR Rankings

MNDR Latest News

MNDR Stock Data

12.11M
16.31M
27.21%
0.43%
1.59%
Health Information Services
Healthcare
Link
United States of America
Singapore